ARNUITY ELLIPTA

This brand name is authorized in Australia, Canada, Japan, New Zealand, Singapore, United States

Active ingredients

The drug ARNUITY ELLIPTA contains one active pharmaceutical ingredient (API):

1 Fluticasone furoate UNII JS86977WNV - FLUTICASONE FUROATE

Fluticasone furoate is a synthetic trifluorinated corticosteroid that possesses a very high affinity for the glucocorticoid receptor and has a potent anti-inflammatory action. Read about Fluticasone furoate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ARNUITY ELLIPTA Inhalation powder	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03BA09		R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11719T, 11729H
Country: CA	Health Products and Food Branch	Identifier(s): 02446561, 02446588
Country: JP	医薬品医療機器総合機構	Identifier(s): 2290705G1029, 2290705G2025
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 18044, 18045
Country: SG	Health Sciences Authority	Identifier(s): 15021P, 15022P
Country: US	FDA, National Drug Code	Identifier(s): 0173-0874, 0173-0876, 0173-0888